Tioma Therapeutics Announces $86 Million Series A Financing
Funding Includes Support of Clinical Development of Anti-CD47 Antibody Program in Multiple Cancer Immunotherapy Trials Executive Team Headed by Biotech Industry Veteran John Donovan ST. LOUIS, MO and BRISBANE, CA -- (Marketwired) -- 08/16/16 -- Tioma …